Effect of silymarin in diabetes mellitus patients with liver diseases

Journal of Pharmacology and Pharmacotherapeutics

Volumn 2, Issue 4, 2011, Pages 287-289

  Jose, Manonmani Alvin ^a   Abraham, Anjana ^a   Narmadha, M P ^a  

^a SWAMY VIVEKANANDHA COLLEGE OF PHARMACY   (India)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE AMINOTRANSFERASE; ALKALINE PHOSPHATASE; ASPARTATE AMINOTRANSFERASE; ASPARTIC ACID; BILIRUBIN; GLUCOSE; INSULIN; ORNITHINE; SERUM ALBUMIN; SILYMARIN;

ADULT; AGED; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ALBUMIN BLOOD LEVEL; ALKALINE PHOSPHATASE BLOOD LEVEL; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; CLINICAL ARTICLE; CLINICAL ASSESSMENT; CLINICAL EFFECTIVENESS; DIABETES MELLITUS; DISEASE ASSOCIATION; DRUG EFFECT; DRUG EFFICACY; FEMALE; GLUCOSE BLOOD LEVEL; HUMAN; INSULIN TREATMENT; LETTER; LIVER CIRRHOSIS; MALE;

EID: 84865509656     PISSN: 0976500X     EISSN: None     Source Type: Journal    
DOI: 10.4103/0976-500X.85952     Document Type: Letter

References (9)

1. rd ed. Edinburgh: Churchill Livingstone; 2003. p. 209-25.
2. Garcia-Compean D, Jaquez-Quintana JO, Gonzalez JA, Maldonado-Garza H. Liver cirrhosis and diabetes: Risk factors, pathophysiology, clinical implications and management. World J Gastroentrol 2009;15:280-8.
3. Xu X, Ling Q, He ZL, Gao F, Zheng SS. Post-transplant diabetes mellitus in liver transplantation: Hangzhou experience. Hepatobiliary Pancreat Dis Int 2008;7:465-70.
4. Hussnain RR, Koukab G, Qayyum M, Asim M, Khanum A. Association of diabetes with hepatitis C virus infected male and female patients along with different risk factors. Int J Agric Biol 2007;9:736-40.
5. Dixit N, Baboota S, Kohli K, Ahmad S, Ali J. Silymarin: A review of Pharmalogical aspects and bioavilability enhancement approches. Indian J Pharamacol 2007;39:172-9.
6. Maghrani M, Zeggwagh NA, Lemhadri A, Amraoui M, Michel J, Eddouks M. Study of the hypoglycaemic activity of silymarin in an animal model of type 1 diabetes mellitus. J Ethnopharmacol 2004;91:309-16.
7. Velussi M, Cernisoi AM, DeMonte A, Dapas F, Caffau C, Zilli M. Long term treatment with an anti-oxidant drug silymarin is effective on hyperinsulinemia exogenous insulin need and malondialdehyde levels in cirrhotic diabetic patients. Hepatology 2005;26:871-9.
8. Huseini H F, Larijani B, Heshmat R, Radjabipour B, Toliat T, Raza M. The efficacy of Silybum marianum Gaertn. in the treatment of type 2 diabetes: A randomized double blind placebo controlled clinical trial. Phytother Res 2006;20:1036-9.
9. Pradhan SC, Girish C. Hepatoprotective herbal drug silymarin from experimental pharmacology to clinical medicine. Indian J Med Res 2006;124:491-504.